These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 6462093)

  • 1. Potential role of thymosin in the treatment of autoimmune diseases.
    Goldstein AL; Zatz MM; Low TL; Jacobs R
    Ann N Y Acad Sci; 1981; 377():486-95. PubMed ID: 6462093
    [No Abstract]   [Full Text] [Related]  

  • 2. Thymosin administration in autoimmune disorders.
    Lavastida MT; Goldstein AL; Daniels JC
    Thymus; 1981 Feb; 2(4-5):287-95. PubMed ID: 6972106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The endocrine thymus: potential role for thymosin in the treatment of autoimmune disease.
    Goldstein AL; Thurman GB; Cohen GH; Rossio JL
    Ann N Y Acad Sci; 1976; 274():390-401. PubMed ID: 786112
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunocytochemical localization of thymosin-alpha 1 in thymic epithelial cells of normal and myasthenia gravis patients and in thymic cultures.
    Dalakas MC; Engel WK; McClure JE; Goldstein AL; Askanas V
    J Neurol Sci; 1981 May; 50(2):239-47. PubMed ID: 7014787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of human thymic epithelial cells with antibodies to thymosin alpha 1 in myasthenia gravis.
    Dalakas MC; Engel WK; McClure JE; Goldstein AL; Askanas V
    Ann N Y Acad Sci; 1981; 377():477-85. PubMed ID: 7041758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research with immunoactive agents.
    Gunby P
    JAMA; 1981 Jul; 246(3):205. PubMed ID: 7017181
    [No Abstract]   [Full Text] [Related]  

  • 7. Thymosin alpha 1 in myasthenia gravis.
    Dalakas MC; Engel WK; McClure JE; Goldstein AL
    N Engl J Med; 1980 May; 302(19):1092-3. PubMed ID: 7366630
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro and in vivo enhancement of mixed lymphocyte culture reactivity by thymosin in patients with primary immunodeficiency disease.
    Wara DW; Barrett DJ; Ammann AJ; Cowan MJ
    Ann N Y Acad Sci; 1979; 332():128-34. PubMed ID: 161150
    [No Abstract]   [Full Text] [Related]  

  • 9. Appearance of thymosin alpha 1 in supernatants of monocytes incubated with prothymosin alpha.
    Frillingos S; Seferiadis K; Papanastasiou M; Baxevanis CN; Frangou-Lazaridis M; Economou M; Papamichail M; Tsolas O
    Arch Biochem Biophys; 1992 Jul; 296(1):256-63. PubMed ID: 1534980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro effect of thymosin on T-lymphocyte rosette formation in rheumatic diseases.
    Moutsopoulos H; Fye KH; Sawada S; Becker MJ; Goldstein A; Talal N
    Clin Exp Immunol; 1976 Dec; 26(3):563-73. PubMed ID: 795579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of thymosin alpha1 fragments on T-lymphocyte transformation in the uremic state.
    Abiko T; Sekino H; Higuchi H
    Chem Pharm Bull (Tokyo); 1980 Nov; 28(11):3411-5. PubMed ID: 6971182
    [No Abstract]   [Full Text] [Related]  

  • 12. T-cell stimulator undergoes diverse testing.
    Gunby P
    JAMA; 1982 Aug; 248(7):807. PubMed ID: 7047781
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of thymosin application upon radiation sickness in mice.
    Vávrová J; Petýrek P
    Folia Biol (Praha); 1976; 22(5):320-9. PubMed ID: 992155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Letter: Antinuclear autoimmunization in Swan mice. Prevention and regression by treatment with thymosin].
    Monier JC; Deschaux P; Fontanges R
    Nouv Presse Med; 1975 Feb; 4(7):507. PubMed ID: 1079341
    [No Abstract]   [Full Text] [Related]  

  • 15. Overview of thymosin activity.
    Marshall GD; Low TL; Thurman GB; Hu SK; Rossio JL; Trivers G; Goldstein AL
    Cancer Treat Rep; 1978 Nov; 62(11):1731-7. PubMed ID: 215305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results and prospects of using thymosin for the purpose of regulating the immune system in different pathological processes and states].
    Grinevich IuA; Kamenets LIa
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Dec; (12):9-15. PubMed ID: 390944
    [No Abstract]   [Full Text] [Related]  

  • 17. [Principles of immunoregulation in autoimmune syndromes].
    Skotnicki AB
    Postepy Hig Med Dosw; 1983; 37(4):345-87. PubMed ID: 6233544
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro and in vivo studies with thymosin in cancer patients.
    Schafer LA; Goldstein AL; Gutterman JU; Hersh EM
    Ann N Y Acad Sci; 1976; 277(00):609-20. PubMed ID: 136916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymosin: basic properties and clinical potential in the treatment of patients with immunodeficiency diseases and cancer.
    Goldstein AL
    Antibiot Chemother (1971); 1978; 24():47-59. PubMed ID: 350140
    [No Abstract]   [Full Text] [Related]  

  • 20. Thymosin: basic properties and clinical application in the treatment of immunodeficiency diseases and cancer.
    Marshall GD; Thurman GB; Low TL; Goldstein AL
    Recent Results Cancer Res; 1980; 75():100-5. PubMed ID: 6262885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.